Literature DB >> 34245963

Trend in COVID-19 vaccination among people with diabetes: A short study from India.

Sukanya Nachimuthu1, Vijay Viswanathan2.   

Abstract

Entities:  

Keywords:  COVID-19 and diabetes; COVID-19 pandemic; COVID-19 vaccine; COVID-19 vaccine and diabetes; Diabetes

Year:  2021        PMID: 34245963      PMCID: PMC8239314          DOI: 10.1016/j.dsx.2021.102190

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


× No keyword cloud information.
With the widely known measures to prevent COVID-19, one more is added to the list. That is, the COVID-19 vaccines which (two vaccines-Covishield: AstraZeneca-Serum Institute of India and Covaxin Bharat Biotech Limited) [1] was authorized by the Drugs Controller General of India (DCGI) for emergency use in India. As people above 60 years and people with co-morbidities above 45 years were announced eligible for vaccination in India, we conducted a survey among our out-patients to know the number of people vaccinated and the reasons for not taking it. This is a cross-sectional, single-centred survey. People with diabetes who attended the out-patient department of MV Hospital for Diabetes, Chennai between March 31, 2021, to April 9, 2021, & were above 18 years of age were approached for this survey and included after receiving their consent [Institutional Ethical Committee approval (IEC/N-008/03/2021)]. A total of 214 participants were surveyed & their mean age were 55.01 years (Mean & Standard deviation (M&SD) = 55.01 ± 11.64; min-25 years & max-83 years). Mean duration of diabetes were 11.15 years (M&SD = 11.15 ± 9.56) (Table 1 ).
Table 1

Results of the survey.

S·NO.VARIABLENUMBER (%)
1.Total participants214
2.Gender
Male112 (52.3%)
Female102 (47.7%)
3.Age (M±SD)55.01 ± 11.64
4.Duration of diabetes (M±SD)11.15 ± 9.56
5.Hypertension78 (36.4%)
6.Cardiac illness32 (15%)
7.Renal impairment26 (12.1%)
8.Previous history of COVID-19 infection16 (7.5%)
9.Treatment received for COVID-19(n=16)
Out-patient7 (43.7%)
Admission9 (56.3%)
10.Received COVD-19 vaccine46 (21.5%)
11.Vaccination details
Covaxin18 (8.4%)
Covishield28 (13%)
12.Received vaccine in(n=46)
Government hospital31 (67.4%)
Private15 (32.6%)
13.Dose received
One dose37 (17.2%)
Two doses9 (4.2%)
14.Reason for not taking the vaccination(n=168)

Need to take after the diabetologist consultation

46 (27.4%)

Age bar (Below 45 years)

35 (20.8%)

Fear

45 (26.8%)

Planning to take soon

11 (6.5%)

Will take after some time (waiting for majority of people to vaccinate)

4 (2.4%)

Health issues (Under Gynecologist consultation, taking aspirin, asthma, doctor advised not to take, afraid as taking medications)

32 (19%)

Not aware about the vaccine

18 (10.7%)

Need to discuss with family members

1 (0.6%)

Not interested/not willing

6 (3.6%)

No COVID-19 cases in the neighbour

1 (0.6%)

Not going out

1 (0.6%)
15.

If age bar, willingness to take? (n=35)

Yes

13 (37.1%)

No (Reason: Fear, health issue)

21 (60%)

After doctor consultation

1 (2.9%)

M±SD-Mean±Standard deviation

Results of the survey. Need to take after the diabetologist consultation Age bar (Below 45 years) Fear Planning to take soon Will take after some time (waiting for majority of people to vaccinate) Health issues (Under Gynecologist consultation, taking aspirin, asthma, doctor advised not to take, afraid as taking medications) Not aware about the vaccine Need to discuss with family members Not interested/not willing No COVID-19 cases in the neighbour Not going out If age bar, willingness to take? (n=35) Yes No (Reason: Fear, health issue) After doctor consultation M±SD-Mean±Standard deviation A total of 7.5% of the study participants had previous history of COVID-19 in which 43.7% participants were treated in outpatient and others as in-patient. Among the study participants, 21.5% (n=46) had taken at least one dose of the COVID-19 vaccine. Approximately 17% (n=37) of the study participants had received only one dose. Both the doses were received by 9 participants (4.2%). Among the vaccinated study participants, 18 participants had received Covaxin, and 28 participants had received Covishield. The majority of the vaccinated study participants received their vaccine at a government facility nearby (n=31, 67.4%). Most of the study participants who have not taken their vaccine mentioned they would take the vaccine after their diabetologist's advice (n = 46, 27.4%). The second reason for not taking the vaccine was fear (n = 45, 26.8%). The other reasons includes: Age bar (n = 35, 20.8%) Health issues (Eg. under gynecologist treatment, due to comorbid conditions like diabetes, hypertension) after physician advice (n = 32, 19%) Not aware of the vaccine (n = 18, 10.7%) Will take soon (n = 11, 6.5%) Not willing (n = 6, 3.6%) Others (n = 2, 1.2%) (Fig. 1 ).
Fig. 1

Reasons for not taken the COVID-19 vaccine.

Reasons for not taken the COVID-19 vaccine. Vaccine hesitations arised from the day of the announcement of the development of vaccines against COVID-19 worldwide. Various reasons for this includes the efficacy of the vaccines, safety, duration of protection, health literacy, misinformation, lack of trust, need for additional information and cost of the vaccines [[2], [3], [4], [5]] as per the studies conducted across countries. Physicians play a crucial role in this education & awareness as the people mostly rely on them for decision making and to break the hesitance.
  5 in total

1.  Determinants of COVID-19 vaccine acceptance among adults with diabetes and in the general population in Israel: A cross-sectional study.

Authors:  Tatyana Kolobov; Simcha Djuraev; Sara Promislow; Orly Tamir
Journal:  Diabetes Res Clin Pract       Date:  2022-06-14       Impact factor: 8.180

2.  The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan.

Authors:  Saeed M Omar; Rehana Khalil; Ishag Adam; Osama Al-Wutayd
Journal:  Vaccines (Basel)       Date:  2022-03-29

3.  The COVID-19 Vaccination Behavior and Correlates in Diabetic Patients: A Health Belief Model Theory-Based Cross-Sectional Study in China, 2021.

Authors:  Lingrui Duan; Ying Wang; Haoyu Dong; Congying Song; Jinping Zheng; Jing Li; Mufan Li; Jiayu Wang; Jianzhou Yang; Junjie Xu
Journal:  Vaccines (Basel)       Date:  2022-04-22

4.  COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia.

Authors:  Eva S L Pedersen; Maria Christina Mallet; Yin Ting Lam; Sara Bellu; Isabelle Cizeau; Fiona Copeland; Trini Lopez Fernandez; Michele Manion; Amanda L Harris; Jane S Lucas; Francesca Santamaria; Myrofora Goutaki; Claudia E Kuehni
Journal:  Vaccines (Basel)       Date:  2021-12-17

5.  Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: A Cross-Sectional Survey.

Authors:  Junjie Xu; Siyu Chen; Ying Wang; Lingrui Duan; Jing Li; Ying Shan; Xinquan Lan; Moxin Song; Jianzhou Yang; Zixin Wang
Journal:  Vaccines (Basel)       Date:  2022-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.